Notably, AFP-L1 experiences elevation in cases of chronic hepatitis and liver cirrhosis, whereas AFP-L3 demonstrates specific elevation solely in hepatocellular carcinoma (HCC). Here, AFP is linked to hepatocellular carcinoma.